Par Pharmaceutical Reports Fourth Quarter and Full Year 20...(assets 56921 72105 ....),Health

Income taxes receivable 17,516 12,422

Total current assets 523,307 518,836

Property, plant and equipment,

at cost less accumulated

depreciation and amortization 82,650 89,155

Available for sale debt and

marketable equity securities 6,690 7,652

Investment in joint venture 6,314 5,292

Other investments 2,500 16,588

Intangible assets, net 36,059 47,880

Goodwill 63,729 63,729

Deferred charges and other assets 2,544 16,000

Non-current deferred income

tax assets, net 57,730 49,545

Total assets $781,523 $814,677

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Short-term and current portion

of long-term debt $200,000 $204,469

Accounts payable 32,200 48,297

Payables due to distribution

agreement partners 36,479 89,585

Accrued salaries and employee

benefits 16,596 15,510

Accrued expenses and other

current liabilities 27,518 18,833

Income taxes payable - 36,932

Total current liabilities 312,793 413,626

Long-term debt, less current portion - -

Other long-term liabilities 30,975 -

Commitments and contingencies

Stockholders' equity:

Preferred Stock, par value $0.0001

per share, authorized 6,000,000

shares; none issued and outstanding - -

Common Stock, par
'/>"/>